Editorial Commentary
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?
Translational Cancer Research
2025;
14
(5)
:2536-2538
.
(30 May 2025)
The promise and translation of cell-free human papillomavirus DNA testing for cervical cancer surveillance
Translational Cancer Research
2025;
14
(5)
:2539-2543
.
(30 May 2025)
“Prime and pull” vaccination strategy for treatment of cervical pre-cancer: not quite ready for prime time
Translational Cancer Research
2025;
14
(5)
:2544-2547
.
(30 May 2025)
Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner?
Translational Cancer Research
2025;
14
(5)
:2548-2552
.
(30 May 2025)
Microsatellite instability (MSI) and the tumor mutation burden (TMB) as biomarkers of response to immune checkpoint inhibitors in prostate cancer
Translational Cancer Research
2025;
14
(5)
:2553-2557
.
(30 May 2025)
When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?—a critical review of LITESPARK-004 results
Translational Cancer Research
2025;
14
(5)
:2558-2562
.
(30 May 2025)
Original Article
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy
Translational Cancer Research
2025;
14
(5)
:2563-2579
.
(30 May 2025)
Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:2580-2593
.
(30 May 2025)
Extracellular vesicles isolated from SphK1 inhibitor SKI II-medium restrain the migration of colorectal cancer
Translational Cancer Research
2025;
14
(5)
:2594-2602
.
(30 May 2025)
Ovarian teratomas causing anti-N-methyl-D-aspartate receptor encephalitis: a case series from west China
Translational Cancer Research
2025;
14
(5)
:2603-2614
.
(30 May 2025)
Differences in esophageal adenocarcinoma survival and treatment modalities by III/IV stage subgroup: a SEER population-based study
Translational Cancer Research
2025;
14
(5)
:2615-2625
.
(30 May 2025)
Identification of the MEX3 family as potential biomarkers of hepatocellular carcinoma based on bioinformatics and experiments
Translational Cancer Research
2025;
14
(5)
:2626-2647
.
(30 May 2025)
GJB2 enhances cancer stem cell properties by modulating SOX2 expression via NF-κB pathway activation in lung adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:2648-2660
.
(30 May 2025)
Construction and validation of a clinical prognostic model for frontal glioblastoma: a real-world clinical study based on radiation therapy
Translational Cancer Research
2025;
14
(5)
:2661-2676
.
(30 May 2025)
Development of a prognostic model for overall survival in neuroblastoma based on Schwann cell-specific genes, clinical predictors, and MYCN amplification
Translational Cancer Research
2025;
14
(5)
:2677-2689
.
(30 May 2025)
Construction and validation of a prognostic model for glioma: an analysis based on mismatch repair-related genes and their correlation with clinicopathological features
Translational Cancer Research
2025;
14
(5)
:2690-2706
.
(30 May 2025)
Increased expression of RIPOR1 predicts the poor prognosis of colorectal cancer patients
Translational Cancer Research
2025;
14
(5)
:2707-2721
.
(30 May 2025)
Effect of periplocin on malignant behavior of oral squamous cell carcinoma cells
Translational Cancer Research
2025;
14
(5)
:2722-2736
.
(30 May 2025)
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking
Translational Cancer Research
2025;
14
(5)
:2737-2757
.
(30 May 2025)
Comprehensive assessment of disulfidptosis-related long non-coding RNA index as biomarkers for predicting clinical outcomes and immune microenvironment in pancreatic cancer
Translational Cancer Research
2025;
14
(5)
:2758-2778
.
(30 May 2025)
Machine learning-driven prognostic model based on sphingolipid-related gene signature in pancreatic cancer: development and validation
Translational Cancer Research
2025;
14
(5)
:2779-2796
.
(30 May 2025)
Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence
Translational Cancer Research
2025;
14
(5)
:2797-2807
.
(30 May 2025)
Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis
Translational Cancer Research
2025;
14
(5)
:2808-2821
.
(30 May 2025)
Development of a prognostic nomogram and risk factor analysis for survival in H. pylori-positive non-cardia gastric adenocarcinoma patients
Translational Cancer Research
2025;
14
(5)
:2822-2834
.
(30 May 2025)
Prognostic role of tumor microenvironment and immune- and autophagy-related genes in colorectal adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:2835-2857
.
(30 May 2025)
Identification and functional analysis of GNAI1 as a biomarker associated with immune-related genes in pediatric acute myeloid leukemia
Translational Cancer Research
2025;
14
(5)
:2858-2873
.
(30 May 2025)
CREB3-mediated upregulation of MIR210HG transcription enhances proliferation in colon cancer cells
Translational Cancer Research
2025;
14
(5)
:2874-2884
.
(30 May 2025)
Construction and validation of a nomogram prediction model for predicting the risk of chemotherapy-induced myelosuppression after chemotherapy in patients with triple-negative breast cancer: a single-center retrospective case-control study
Translational Cancer Research
2025;
14
(5)
:2885-2899
.
(30 May 2025)
Development and validation of prognostic models based on cell cycle-related signatures for predicting the prognosis of patients with lung adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:2900-2915
.
(30 May 2025)
Race, gender, and safety: exposing biases in minimally invasive lung cancer surgery research
Translational Cancer Research
2025;
14
(5)
:2916-2925
.
(30 May 2025)
Overexpression of LINC00880 promotes colorectal cancer growth
Translational Cancer Research
2025;
14
(5)
:2926-2939
.
(30 May 2025)
In silico development and validation of a novel six-gene-derived signature in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(5)
:2940-2955
.
(30 May 2025)
Prognostic value of lactate dehydrogenase to albumin ratio in first-line chemoimmunotherapy for locally advanced or metastatic non-small cell lung cancer
Translational Cancer Research
2025;
14
(5)
:2956-2965
.
(30 May 2025)
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non-small cell lung cancer
Translational Cancer Research
2025;
14
(5)
:2966-2980
.
(30 May 2025)
Identification of a novel prognostic gene signature in pleural mesothelioma: a study based on The Cancer Genome Atlas database and experimental validation
Translational Cancer Research
2025;
14
(5)
:2981-2998
.
(30 May 2025)
Integrated analysis of uterine leiomyosarcoma and leiomyoma utilizing TCGA and GEO data: a WGCNA and machine learning approach
Translational Cancer Research
2025;
14
(5)
:2999-3016
.
(30 May 2025)
Prognostic significance of IL11RA and its methylation in lung adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:3017-3034
.
(30 May 2025)
Deep learning for fine-grained molecular-based colorectal cancer classification
Translational Cancer Research
2025;
14
(5)
:3035-3046
.
(30 May 2025)
The role of radiotherapy in distant nasopharyngeal carcinoma: a SEER analysis
Translational Cancer Research
2025;
14
(5)
:3047-3056
.
(30 May 2025)
Machine learning and deep learning to improve overall survival prediction in cervical cancer patients
Translational Cancer Research
2025;
14
(5)
:3057-3068
.
(30 May 2025)
The prognostic and immune significance of fibronectin type III domain-containing 1 gene in pan-cancer and its relationship with proliferation and migration of stomach adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:3069-3095
.
(30 May 2025)
Developing a prognostic risk model based on circulating tumor cell genes to predict prognosis and provide potential therapeutic strategies in colorectal cancer
Translational Cancer Research
2025;
14
(5)
:3096-3112
.
(30 May 2025)
Identification and validation of hypoxia-associated genes positively correlated with HIF1A in pulmonary adenocarcinoma
Translational Cancer Research
2025;
14
(5)
:3113-3132
.
(30 May 2025)
The lncRNA MIR22HG suppresses prostate cancer cell proliferation, migration, and epithelial-mesenchymal transition via the miR-4428/PCDH9 axis
Translational Cancer Research
2025;
14
(5)
:3133-3148
.
(30 May 2025)
Ubiquitin-specific peptidase 20 affects immune cell infiltration by regulating prostaglandin E2 on intraperitoneal metastasis model of colorectal cancer
Translational Cancer Research
2025;
14
(5)
:3149-3160
.
(30 May 2025)
A real-world retrospective cohort study: the clinical outcomes and characteristics of platinum-resistant recurrent ovarian cancer
Translational Cancer Research
2025;
14
(5)
:3161-3174
.
(30 May 2025)
The high expression of Long noncoding RNA TEX41 promotes the proliferation, migration, and invasion of hepatocellular carcinoma
Translational Cancer Research
2025;
14
(5)
:3175-3185
.
(30 May 2025)
Plasma-derived exosomal human epidermal growth factor receptor 2 (HER2) protein for distinguishing breast cancer from benign breast disease and assessing the efficacy of neoadjuvant therapy
Translational Cancer Research
2025;
14
(5)
:3186-3200
.
(30 May 2025)
Immunocytochemical staining for p16, Ki-67, and MCM2 in the detection of cervical lesions and cancer: a prospective observational study
Translational Cancer Research
2025;
14
(5)
:3201-3211
.
(30 May 2025)
Significant weight gain benefits of nanocrystalline megestrol acetate for patients with cancer anorexia-cachexia syndrome
Translational Cancer Research
2025;
14
(5)
:3212-3225
.
(30 May 2025)
Sphingosine kinase 1 facilitates gastric cancer progression via STAT1 gene methylation-mediated mechanisms
Translational Cancer Research
2025;
14
(5)
:3226-3238
.
(30 May 2025)
Review Article
Ovarian cancer and malnutrition: a literature review
Translational Cancer Research
2025;
14
(5)
:3239-3254
.
(30 May 2025)
Case Report
Endobronchial malignancy as a manifestation of advanced ovarian cancer recurrence: a case report and literature review
Translational Cancer Research
2025;
14
(5)
:3255-3262
.
(30 May 2025)
Erratum
Erratum: The prognostic significance of fragile X mental retardation syndrome-related protein 1 (FXR1) in breast cancer
Translational Cancer Research
2025;
14
(5)
:3263
.
(30 May 2025)
Erratum: Limonin inhibits angiogenesis and metastasis of human breast cancer cells by suppressing the VEGFR2/IGFR1-mediated STAT3 signaling pathway
Translational Cancer Research
2025;
14
(5)
:3264-3269
.
(30 May 2025)
Retraction
Retraction: TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types
Translational Cancer Research
2025;
14
(5)
:3270
.
(30 May 2025)
Retraction: H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition
Translational Cancer Research
2025;
14
(5)
:3271
.
(30 May 2025)
